Theodoros Kelesidis Selected Research

mitoquinol

3/2022

Mitoquinone mesylate targets SARS-CoV-2 and associated lung inflammation through host pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodoros Kelesidis Research Topics

Disease

24	Infections 03/2022 - 11/2008
17	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 01/2014
14	Atherosclerosis 01/2021 - 07/2012
13	Inflammation (Inflammations) 03/2022 - 02/2011
11	HIV Infections (HIV Infection) 01/2022 - 02/2011
7	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2010
5	Insulin Resistance 01/2022 - 02/2007
4	Obesity 02/2009 - 03/2007
3	COVID-19 03/2022 - 12/2021
3	Type 2 Diabetes Mellitus (MODY) 02/2022 - 02/2007
3	Viremia 01/2017 - 02/2011
3	Neoplasms (Cancer) 04/2010 - 09/2009
2	Pneumonia (Pneumonitis) 03/2022 - 11/2010
2	Weight Gain 01/2022 - 02/2009
2	Glucose Intolerance 01/2022 - 02/2007
2	Body Weight (Weight, Body) 01/2019 - 10/2013
2	Bone Diseases (Bone Disease) 01/2018 - 07/2014
2	Arthritis (Polyarthritis) 05/2010 - 01/2010
2	Hypoglycemia (Reactive Hypoglycemia) 02/2010 - 03/2009
2	Breast Neoplasms (Breast Cancer) 04/2007 - 03/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Cellulitis 12/2019
1	Fatty Liver 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Neurocognitive Disorders (Clerambault Syndrome) 10/2015
1	Virus Diseases (Viral Diseases) 11/2014

Drug/Important Bio-Agent (IBA)

13	LipidsIBA 01/2022 - 02/2007
11	HDL LipoproteinsIBA 11/2022 - 10/2013
8	AdiponectinIBA 01/2022 - 02/2007
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2007
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2012
5	Antiviral Agents (Antivirals)IBA 03/2022 - 04/2010
5	AntioxidantsIBA 01/2022 - 02/2011
5	Lipopolysaccharide ReceptorsIBA 01/2021 - 11/2012
5	Daptomycin FDA Link 07/2015 - 11/2011
4	C-Reactive ProteinIBA 01/2022 - 10/2014
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 02/2011
4	Raltegravir Potassium FDA Link 01/2022 - 08/2015
4	fibrin fragment D (D-dimer)IBA 12/2019 - 10/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 03/2009
4	Protease Inhibitors (Protease Inhibitor)IBA 11/2016 - 11/2012
3	LeptinIBA 01/2022 - 02/2009
3	Emtricitabine (Emtriva)FDA Link 01/2022 - 09/2016
3	Tenofovir (Viread)FDA Link 01/2022 - 09/2016
3	Interleukin-6 (Interleukin 6)IBA 12/2021 - 08/2015
3	OsteoprotegerinIBA 01/2018 - 06/2013
3	CholesterolIBA 11/2017 - 06/2013
3	Lipoproteins (Lipoprotein)IBA 11/2017 - 11/2016
2	Ritonavir (Norvir)FDA Link 01/2022 - 08/2015
2	SmokeIBA 01/2022 - 01/2021
2	Nicotine FDA Link 01/2022 - 01/2021
2	Darunavir (Prezista)FDA Link 01/2022 - 08/2015
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 08/2015
2	Advanced Glycation End ProductsIBA 10/2021 - 06/2018
2	EndotoxinsIBA 01/2021 - 11/2012
2	HDL CholesterolIBA 12/2019 - 10/2017
2	RANK LigandIBA 01/2018 - 07/2014
2	Indicators and Reagents (Reagents)IBA 01/2017 - 03/2013
2	RNA (Ribonucleic Acid)IBA 11/2016 - 10/2014
2	Glucose (Dextrose)FDA LinkGeneric 09/2016 - 02/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014 - 05/2010
2	Linezolid (Zyvox)FDA Link 01/2013 - 11/2011
2	Tigecycline (Tygacil)FDA Link 11/2010 - 11/2008
2	Levofloxacin (Levaquin)FDA Link 05/2010 - 03/2009
1	mitoquinolIBA 03/2022
1	Mesylates (Mesylate)IBA 03/2022
1	Caspase 3 (Caspase-3)IBA 03/2022
1	mitoquinoneIBA 03/2022
1	PeroxidesIBA 02/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	AdipokinesIBA 01/2022
1	FurinIBA 01/2022
1	apolipoprotein A-I mimetic peptide 4FIBA 12/2021
1	CytokinesIBA 12/2021
1	lipopolysaccharide-binding proteinIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2019
1	5-HT2C Serotonin ReceptorIBA 01/2019
1	lorcaserinIBA 01/2019
1	Lipid PeroxidesIBA 06/2018
1	erucylphosphocholineIBA 01/2018
1	Oxidants (Oxidizing Agents)IBA 11/2017
1	AlbuminsIBA 01/2017
1	HLA-DR Antigens (HLA-DR)IBA 11/2016
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 11/2016
1	Receptor for Advanced Glycation End ProductsIBA 08/2016
1	Platelet Activating FactorIBA 10/2015
1	Integrase InhibitorsIBA 08/2015
1	Ampicillin (Omnipen)FDA LinkGeneric 07/2015
1	Viral ProteinsIBA 11/2014
1	Interleukin-8 (Interleukin 8)IBA 10/2014

Therapy/Procedure

20	Therapeutics 01/2022 - 04/2010
6	Art Therapy 01/2022 - 08/2015
1	Ventriculoperitoneal Shunt 01/2015